Preclinical evaluation of pions in vivo: experience at TRIUMF.
This paper describes the results obtained from in vivo studies of the pion beam at the TRI University Meson Facility (TRIUMF). The studies encompass work (from 1978 to 1986), designed to evaluate the RBE for early and late effects and to assess the importance of X-ray dose rate and treatment volume on these values. Results with early responding tissues, i.e. mouse and pig skin and mouse intestine indicate a pion RBE of about 1.5 in the clinically relevant dose per fraction range of 2-3 Gy. At these doses, RBE appears to be independent of the reference X-ray dose rate. However, at high doses per fraction, the RBE values become increasingly X-ray dose rate dependent. The induction of late effects by pions has been assessed by monitoring the late dermal response of pig skin; late fibrosis was not assessed in this study. The values obtained using the chosen endpoint indicate that the RBE is not significantly higher than that seen in any of the early responding tissues for pion doses as low as 2-3 Gy per fraction. The effect of increasing the treatment volume for pion therapy has been assessed using mouse intestine. The results show that for a constant field size, RBE decreases with increasing peak width. However, if peak width is held constant and field size increased, there is evidence for an increased RBE.(ABSTRACT TRUNCATED AT 250 WORDS)
Chaplin
D J
DJ
Medical Biophysics Unit, B.C. Cancer Research Centre, Vancouver, Canada.
Douglas
B G
BG
Saito
T
T
Skarsgard
L D
LD
Lam
G K
GK
Denekamp
J
J
D000818:Animals; D004601:Elementary Particles; D005260:Female; D007583:Jejunum / Q000528:radiation effects*; D008297:Male; D008651:Mesons; D051379:Mice; D010315:Particle Accelerators; D011829:Radiation Dosage; D012062:Relative Biological Effectiveness; D012867:Skin / Q000528:radiation effects*; D013552:Swine; D013997:Time Factors; D014965:X-Rays